AMENDMENT NO. 4 TO OPTION, LICENSE AND COLLABORATION AGREEMENTOption, License and Collaboration Agreement • August 8th, 2024 • Arcus Biosciences, Inc. • Pharmaceutical preparations
This Amendment No. 4 (“Amendment No. 4”) to the Option, License and Collaboration Agreement, dated as of May 2, 2020, as amended November 17, 2021, May 12, 2023 and January 29, 2024 (collectively, the “Agreement”), is entered into as of May 10, 2024 (the “Amendment No. 4 Execution Date”), by and between Gilead Sciences, Inc. (“Gilead”) and Arcus Biosciences, Inc. (“Arcus”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Agreement to the extent defined therein.
